Majid Afshar1,2,3, Ellen L Burnham4, Cara Joyce3, Brendan J Clark4, Meagan Yong1,2, Jeannette Gaydos4, Richard S Cooper3, Gordon S Smith5, Elizabeth J Kovacs6, Erin M Lowery1,2. 1. Stritch School of Medicine , Burn and Shock Trauma Research Institute, Loyola University Health Sciences Campus, Maywood, Illinois. 2. Alcohol Research Program , Stritch School of Medicine, Loyola University Health Sciences Campus, Maywood, Illinois. 3. Department of Public Health Sciences , Stritch School of Medicine, Loyola University Chicago Health Sciences Campus, Maywood, Illinois. 4. Department of Medicine , Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado. 5. Shock Trauma and Anesthesiology Research (STAR) - Organized Research Center , Department of Surgery, University of Maryland, Baltimore, Maryland. 6. Department of Surgery , University of Colorado School of Medicine, Aurora, Colorado.
Abstract
BACKGROUND: Although alcohol misuse is associated with deleterious outcomes in critically ill patients, its detection by either self-report or examination of biomarkers is difficult to obtain consistently. Phosphatidylethanol (PEth) is a direct alcohol biomarker that can characterize alcohol consumption patterns; however, its diagnostic accuracy in identifying misuse in critically ill patients is unknown. METHODS: PEth values were obtained in a mixed cohort comprising 122 individuals from medical and burn intensive care units (n = 33), alcohol detoxification unit (n = 51), and healthy volunteers (n = 38). Any alcohol misuse and severe misuse were referenced by Alcohol Use Disorders Identification Test (AUDIT) and AUDIT-C scores separately. Mixed-effects logistic regression analysis was performed, and the discrimination of PEth was evaluated using the area under the receiver-operating characteristic (ROC) curve. RESULTS: The area under the ROC curve for PEth was 0.927 (95% CI: 0.877, 0.977) for any misuse and 0.906 (95% CI: 0.850, 0.962) for severe misuse defined by AUDIT. By AUDIT-C, the area under the ROC curves was 0.948 (95% CI: 0.910, 0.956) for any misuse and 0.913 (95% CI: 0.856, 0.971) for severe misuse. The PEth cut-points of ≥250 and ≥400 ng/ml provided optimal discrimination for any misuse and severe misuse, respectively. The positive predictive value for ≥250 ng/ml was 88.7% (95% CI: 77.5, 95.0), and the negative predictive value was 86.7% (95% CI: 74.9, 93.7). PEth ≥ 400 ng/ml achieved similar values, and similar results were shown for AUDIT-C. In a subgroup analysis of critically ill patients only, test characteristics were similar to the mixed cohort. CONCLUSIONS: PEth is a strong predictor and has good discrimination for any and severe alcohol misuse in a mixed cohort that includes critically ill patients. Cut-points at 250 ng/ml for any, and 400 ng/ml for severe, are favorable. External validation will be required to establish these cut-points in critically ill patients.
BACKGROUND: Although alcohol misuse is associated with deleterious outcomes in critically illpatients, its detection by either self-report or examination of biomarkers is difficult to obtain consistently. Phosphatidylethanol (PEth) is a direct alcohol biomarker that can characterize alcohol consumption patterns; however, its diagnostic accuracy in identifying misuse in critically illpatients is unknown. METHODS:PEth values were obtained in a mixed cohort comprising 122 individuals from medical and burn intensive care units (n = 33), alcohol detoxification unit (n = 51), and healthy volunteers (n = 38). Any alcohol misuse and severe misuse were referenced by Alcohol Use Disorders Identification Test (AUDIT) and AUDIT-C scores separately. Mixed-effects logistic regression analysis was performed, and the discrimination of PEth was evaluated using the area under the receiver-operating characteristic (ROC) curve. RESULTS: The area under the ROC curve for PEth was 0.927 (95% CI: 0.877, 0.977) for any misuse and 0.906 (95% CI: 0.850, 0.962) for severe misuse defined by AUDIT. By AUDIT-C, the area under the ROC curves was 0.948 (95% CI: 0.910, 0.956) for any misuse and 0.913 (95% CI: 0.856, 0.971) for severe misuse. The PEth cut-points of ≥250 and ≥400 ng/ml provided optimal discrimination for any misuse and severe misuse, respectively. The positive predictive value for ≥250 ng/ml was 88.7% (95% CI: 77.5, 95.0), and the negative predictive value was 86.7% (95% CI: 74.9, 93.7). PEth ≥ 400 ng/ml achieved similar values, and similar results were shown for AUDIT-C. In a subgroup analysis of critically illpatients only, test characteristics were similar to the mixed cohort. CONCLUSIONS:PEth is a strong predictor and has good discrimination for any and severe alcohol misuse in a mixed cohort that includes critically illpatients. Cut-points at 250 ng/ml for any, and 400 ng/ml for severe, are favorable. External validation will be required to establish these cut-points in critically illpatients.
Authors: Susanne Hartmann; Steina Aradottir; Marc Graf; Gerhard Wiesbeck; Otto Lesch; Katrin Ramskogler; Manfred Wolfersdorf; Christer Alling; Friedrich Martin Wurst Journal: Addict Biol Date: 2007-03 Impact factor: 4.280
Authors: Geoffrey M Silver; Joslyn M Albright; Carol R Schermer; Marcia Halerz; Peggie Conrad; Paul D Ackerman; Linda Lau; Mary Ann Emanuele; Elizabeth J Kovacs; Richard L Gamelli Journal: J Burn Care Res Date: 2008 Sep-Oct Impact factor: 1.845
Authors: Scott H Stewart; Adrian Reuben; Walter A Brzezinski; David G Koch; Jan Basile; Patrick K Randall; Peter M Miller Journal: Alcohol Alcohol Date: 2009-06-17 Impact factor: 2.826
Authors: Friedrich M Wurst; Natasha Thon; Michel Yegles; Alexandra Schrück; Ulrich W Preuss; Wolfgang Weinmann Journal: Alcohol Clin Exp Res Date: 2015-09-07 Impact factor: 3.455
Authors: Kirsha S Gordon; Kathleen McGinnis; Cecilia Dao; Christopher T Rentsch; Aeron Small; Rachel Vickers Smith; Rachel L Kember; Joel Gelernter; Henry R Kranzler; Kendall J Bryant; Janet P Tate; Amy C Justice Journal: AIDS Behav Date: 2020-02
Authors: Majid Afshar; Ellen L Burnham; Cara Joyce; Robin Gagnon; Robert Dunn; Joslyn M Albright; Luis Ramirez; John E Repine; Giora Netzer; Elizabeth J Kovacs Journal: Ann Surg Date: 2019-12 Impact factor: 12.969
Authors: Tekeda F Ferguson; Katherine P Theall; Meghan Brashear; Vincent Maffei; Alaina Beauchamp; Robert W Siggins; Liz Simon; Donald Mercante; Steve Nelson; David A Welsh; Patricia E Molina Journal: Alcohol Clin Exp Res Date: 2020-05-22 Impact factor: 3.455
Authors: Majid Afshar; Kenneth Baker; Josefine Corral; Erin Ross; Erin Lowery; Richard Gonzalez; Ellen L Burnham; Rachael A Callcut; Lucy Z Kornblith; Carolyn Hendrickson; Elizabeth J Kovacs; Cara Joyce Journal: Ann Surg Date: 2021-03-10 Impact factor: 13.787
Authors: Melynda S Coker; Kaylee R Ladd; Jimin Kim; Carl J Murphy; Ryan DeCort; Bradley R Newcomer; Robert R Wolfe; Robert H Coker Journal: Nutrients Date: 2020-01-19 Impact factor: 5.717